Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the basque country of Spain

Pediatric Infectious Disease Journal

Volumn 29, Issue 12, 2010, Pages 1142-1144

  Benito Fernández, Javier ^a   Mintegi, Santiago ^a   Pocheville Gurutzeta, Itziar ^a   Sánchez Etxaniz, Jesús ^a   Gómez Cortés, Borja ^a   Hernández Almaraz, Jose Luis ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

febrile infants; pneumococcal bacteremia; pneumococcal conjugate vaccine

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTEREMIA; BLOOD CULTURE; CHILD; CONTROLLED STUDY; EMERGENCY WARD; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; OCCULT BACTEREMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SPAIN; STAPHYLOCOCCAL BACTEREMIA; STREPTOCOCCUS PNEUMONIAE;

BACTEREMIA; CHILD, PRESCHOOL; EMERGENCY MEDICAL SERVICES; HOSPITALIZATION; HUMANS; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 78650420371     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181eaf89a     Document Type: Article

References (10)

1. Benito-Fernández J, Raso SM, Pocheville-Gurutzeta I, et al. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J. 2007;26:667-671.
2. Hausdorff WP, Dagan R, Beckers F, et al. Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine. 2009;27:7257-7269.
3. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197-e209.
4. Salleras L, Domínguez A, Ciruela P, et al. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. Clin Microbiol Infect. 2009; 15:997-1001.
5. Muñoz-Almagro C, Jordan I, Gene A, et al. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;46:174-182.
6. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998- 2004. J Infect Dis. 2007;196:1346-1354.
7. Kaplan SL, Barson WJ, Lin PL, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010;125:429-436.
8. Wilkinson M, Bulloch B, Smith M. Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med. 2009;16:220-225.
9. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001;108:835-844.
10. Avner JR, Baker MD. Occult bacteremia in the post-pneumococcal conjugate vaccine era: does the blood culture stop here? Acad Emerg Med. 2009;16:258-260.